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Bisphenol A and Risk
Assessment
In a recent article, vom Saal and Hughes
(2005) proposed that a new risk assessment
on bisphenol A (BPA) is needed because of
the availability of extensive new literature,
including “recent epidemiologic evidence
that BPA is related to disease in women.”
Specifically, the only research that vom Saal
and Hughes cited as evidence relating BPA to
disease is a study by Takeuchi et al. (2004),
which they describe as a case–control study
that reports that ovarian disease in women is
related to blood levels of BPA. 
Vom Saal and Hughes (2005) have mis-
represented the Takeuchi study (Takeuchi
et al. 2004): It is not a case–control study,
and it does not demonstrate that BPA is
specifically associated with ovarian disease. 
Takeuchi et al. (2004) conducted a small
cross-sectional descriptive study that assessed
73 women with respect to serum BPA, hor-
mone concentrations, and their clinical con-
dition at a single point in time. Women
were categorized clinically as normal (either
obese or nonobese), or as having hyper-
prolactinemia, hypothalamic amenorrhea, or
polycystic ovary syndrome (PCOS) (again,
either obese or nonobese). The six groups in
the study each contained as many as 19 sub-
jects (nonobese normal group) and as few as
6 subjects (PCOS obese group). The authors
reported that serum BPA was higher in
women with PCOS (both obese and not
obese) and obese normal women than nor-
mal women who were not obese. There were
also significant positive correlations between
serum BPA and various androgens. Takeuchi
et al. (2004) concluded that there is a strong
relationship between serum BPA and andro-
gen, and they noted that there are a number
of possible explanations for this relationship. 
Takeuchi et al. (2004) appropriately
acknowledged that their study was a
hypothesis-generating study and they did not
attempt to draw conclusions about causal
relationships. 
Vom Saal and Hughes (2005) overstated
the importance of this low-level epidemio-
logic evidence by referring to it as a case–
control study. A case–control study is a more
rigorous epidemiologic study in which a
group of cases (i.e., with the disease of inter-
est) is compared to a group of controls (i.e.,
without the disease of interest) with respect
to exposures that occurred before the devel-
opment of disease. Rather, Takeuchi et al.
(2004) conducted a cross-sectional study in
which both exposure and disease were
assessed at a single point in time. When both
exposure and outcome are assessed at a single
point in time, it is not possible to determine
whether the exposure preceded the clinical
condition or whether the clinical condition
affected the individual’s level of exposure. A
cross-sectional study cannot test hypotheses;
at most, it can merely examine correlations.
Furthermore, cross-sectional studies cannot
control for confounding factors that may
obscure the true relationship between expo-
sure and disease (Hennekens and Buring
1987). 
Vom Saal and Hughes (2005) overlooked
the intended primary focus of the paper by
Takeuchi et al. (2004), which is that there is a
relationship between serum BPA and andro-
gen levels. The exact nature of this relation-
ship is not known at this time and Takeuchi
et al. (2004) speculate that BPA may stimu-
late androgen production, or, more likely,
androgen may suppress the metabolism of
BPA. Consequently, women who have clini-
cal conditions that are associated with ele-
vated androgen (e.g., PCOS or obesity) may
have elevated levels of BPA as a result of their
elevated androgen. The cross-sectional study
by Takeuchi et al. cannot shed light on the
time course of events and, therefore, cannot
address causal relationships among any of the
variables studied in these women. 
In addition, a number of recent studies
have reported that several of the ELISA kits
available for measurement of serum BPA
[the analytic method used by Takeuchi et al.
(2004)] overestimate BPA concentrations
and exhibit considerable cross-reactivity,
calling into question the validity of results
generated by such methods (Fukata and
Mori 2004; Fukata et al. 2003; Kawaguchi
et al. 2003). Furthermore, it is well known
that BPA is metabolized and eliminated
rapidly (Volkel et al. 2002), so serum levels
provide only a snapshot of BPA exposure
within the last day. It is not meaningful to
correlate an acute exposure (serum BPA at
one time-point) with a chronic disease that
took years to develop. Chronic exposure to
BPA would have to be demonstrated and
not assumed. 
The Takeuchi et al. (2004) study sug-
gests a hypothesis that could be further
examined in an appropriately controlled ana-
lytic study. It should not be portrayed as
recent epidemiologic evidence that demon-
strates an association between blood levels of
BPA and clinical disease in women. 
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Bisphenol A: vom Saal and
Hughes Respond
Our commentary describing the extensive
new literature reporting low-dose effects of
bisphenol A (BPA) in experimental animals
(vom Saal and Hughes 2005) was written in
response to a report from the Harvard Center
for Risk Analysis (HCRA) by Gray et al.
(2004), who concluded that “the weight of
the evidence for low-dose effects [of BPA] is
very weak.” The HCRA report was funded by
the American Plastics Council and involved a
selective review of only 19 of a much larger
number of studies that could have been
reviewed. In our commentary we showed that
a comprehensive review of the now extensive
literature concerning studies in experimental
animals that used doses of BPA within the
range of human exposure led to exactly the
opposite conclusion from that reached in the
HCRA report (Gray et al. 2004), which was
released 2.5 years after it was written.
At this time there are only two published
epidemiologic studies showing a relationship
between blood levels of BPA and diseases in
humans. In his letter, Politch focuses his
attention on a single study by Takeuchi et al.
(2004) that describes a relationship between
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(PCOS) in Japanese women. In a second
recently published article, Sugiura-Ogasawara
et al. (2005) reported a relationship between
blood levels of BPA and recurrent miscarriage
in Japanese women. Politch seeks to deflect
attention from the central issue of our review
by focusing only on the study by Takeuchi
et al. (2004) and stating that such studies
“cannot address causal relationships” and sug-
gesting that “appropriately controlled” human
studies are required. We are certain that read-
ers of Environmental Health Perspectives
(EHP) realize that these are criticisms that can
be directed at all epidemiologic studies, which
can never achieve the control required in lab-
oratory experiments. Additionally, there is
always some risk in arguing the methodologic
details of a peer-reviewed publication in one
field of scientific research (epidemiology)
when the commentator’s core expertise (bio-
psychology) lies elsewhere. Most importantly,
based on his criticism of the levels of BPA
reported in the blood of women by Takeuchi
et al. (2004), Politch appears to be unaware of
the large literature concerning the levels of
BPA in human blood, urine, and tissues from
studies conducted in different regions of the
world reporting virtually identical mean
and/or median values. For example, in a
recent study at the Centers for Disease
Control and Prevention, Calafat et al. (2005)
found BPA in 95% of the human urine sam-
ples they assayed—in the same range reported
in human blood in other studies (e.g.,
Schonfelder et al. 2002; Tan and Mohd
2003). All of this published literature is listed
in a document available on the University of
Missouri Endocrine Disruptor web site
(Endocrine Disruptors Group 2005).
One point-of-view expressed by Politch
that we strongly support is the proposition
that human studies linking developmental
exposure with adult disease are also required,
based on the extensive evidence that the
developing fetus and neonate are the most
vulnerable to endocrine disruption. We hope
that the planned National Children’s Study
will address this issue and begin to character-
ize which exposures are and are not conse-
quential for human health. In the absence of
such a study, which will take decades to
complete, we rely on experimental studies in
animals to make decisions regarding the
potential hazards posed by chemicals. 
Our comment that the epidemiologic evi-
dence “adds to our concern” about the poten-
tial hazards posed to humans by BPA hardly
qualifies as justification for the criticism that
we “overstated the importance” of this or any
other single study. Our concern about the
potential hazards of BPA to humans is justi-
fied by the fact that the limited epidemio-
logic studies do follow and generally support
findings from over 125 experiments with
laboratory animals showing that low doses of
BPA cause adverse effects on a wide range of
outcomes. We also pointed out in our article
(vom Saal and Hughes 2005) that 100% of
the studies showing significant effects of
BPA in laboratory animals were funded by
government agencies, and 100% of the stud-
ies funded by chemical corporations con-
clude that the same low doses of BPA do not
cause significant effects. What is crucial in
relation to the critique by Politch is that the
two epidemiologic studies relating BPA in
blood to diseases in women are consistent
with the findings from studies of the hazards
of BPA in animals at doses that lead to blood
levels in animals within and below those
detected in human blood.
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The Human Population:
Accepting Species Limits
In “The Population Equation: Balancing
What We Need with What We Have,” Dahl
(2005) presented generally accepted thought
and consensually validated data regarding the
human population, even though he did not
include an adequate scientific theory of
absolute human population numbers. Dahl
also appeared to confirm the wide agreement
among scientists that it is difficult to make
theoretical advances or conduct human popu-
lation research because humankind is seen as
essentially different from other species and the
human world is viewed as being composed of
many intricately connected things that inter-
act in extremely complex ways. Therefore, the
population dynamics of Homo sapiens are
effectively relegated to the preternatural realm
and are believed to include a number of fac-
tors that are so complicated and enormous as
to be unsuitable for empirical research or else
unknowable.
A theory of human population numbers
that could objectively explain the increase
and decrease of the human population would
be useful. Perhaps correlation data from
Hopfenberg and Pimentel (2001) and the
recent mathematical formulation of this bio-
logic phenomenon by Hopfenberg (2003)
provide a basis for an apparently unexpected
theoretical perspective. According to the
empirical research (Hopfenberg 2003),
human population growth is a rapidly cycling
positive feedback loop in which food avail-
ability drives population growth and this
growth in human numbers gives rise to the
mistaken impression that food production
needs to be increased even more.
The data of Hopfenberg (2003) and
Hopfenberg and Pimentel (2001) indicate
that the world’s human population—all seg-
ments of it—grows by approximately 2% per
year, including more people with brown eyes
and more with blue eyes; more tall people and
more short people; and more people who
grow up well fed and more who grow up
hungry. We may or may not be reducing
hunger by increasing food production; how-
ever, we are most certainly producing more
and more hungry people. The evidence sug-
gests that the remarkably successful efforts of
humankind to increase food production to
feed a growing population results in even
greater increase in population numbers. 
Hopfenberg and Pimentel (2001) pointed
out that the perceived need to increase food
production to feed a growing population is a
misperception, a denial of the physical reality
of the space–time dimension. If people are
starving at a given moment in time, increas-
ing food production cannot help them. Are
these starving people supposed to be waiting
for sowing, growing, and reaping to be com-
pleted? Are they supposed to wait for sur-
pluses to reach them? Without food they
would die. In such circumstances, increasing
food production for people who are starving
is like tossing parachutes to people who have
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duced food arrives too late. However, this
does not mean human starvation is inevitable.
If this view of the human population is
somehow correct, then human population
dynamics are not biologically different in
essence from the population dynamics of
other species (Hopfenberg and Pimentel
2001). We do not find hoards of starving
roaches, birds, squirrels, alligators, or chim-
panzees in the absence of food as we do in
many civilized human communities today,
because these nonhuman species are not
annually increasing their own production of
food. Among tribal peoples in remote origi-
nal habitats, we do not find people starving.
Like nonhuman species, “primitive” human
beings live within the carrying capacity of
their environment. History is replete with
examples of early humans and other ances-
tors not increasing their food production
annually, but rather living successfully off
the land for thousands of years as hunters
and gatherers of food. Before the agricul-
tural revolution and the production of more
food than was needed for immediate sur-
vival, human numbers supposedly could not
grow beyond their environment’s physical
capacity to sustain them because human
population growth or decline is primarily a
function of food availability (Hopfenberg
2003; Hopfenberg and Pimentel 2001).
Given its current scale and rate of growth,
the human population worldwide has identi-
fiable, potentially destructive ecological conse-
quences. From this theoretical perspective,
recent global human population growth can
be understood as a primary causative factor of
a range of phenomena including biodiversity
loss and environmental degradation.
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Sources of Blood Lead in
Children
In their article on seasonality and children’s
blood lead (BPb) levels, Laidlaw et al. (2005)
stated that “lead-contaminated soil in and of
itself may be the primary driving mechanism
of child BPb poisoning in the urban envi-
ronment.” We believe that the data pre-
sented by Laidlaw et al. (2005) do not
support this conclusion and that they mis-
represent the many other studies of child-
hood lead poisoning, which support a more
comprehensive, validated approach.
To support their “soil-only” hypothesis,
Laidlaw et al. (2005) made three primary
arguments: a) soil lead represents a large and
available reservoir of environmental lead;
b) resuspension of lead from contaminated
soil followed by inhalation of airborne partic-
ulate matter < 10 µm in diameter (PM10)
and dust deposition on interior surfaces is the
major source of lead exposure to children;
and c) the major source of lead contaminated
soil is fallout from the past use of tetraethyl
lead in gasoline. 
Laidlaw et al. (2005) did not cite the
compelling body of scientific evidence
demonstrating that deteriorated lead-based
paint and the contaminated dust and soil it
generates is highly correlated with BPb levels
in children. These have been reviewed at
length elsewhere (National Academy of
Sciences 1993; Jacobs 1995; President’s Task
Force on Environmental Health Risks and
Safety Risks to Children 2000). Indeed,
Laidlaw et al. failed to recognize the enlight-
ened statutory definition of the term “lead-
based paint hazard,” which includes not only
deteriorated lead-based paint but also interior
settled house dust and bare soil. Together,
these constitute the principal exposure
sources and pathways for most (but not all)
children today (Residential Lead-Based Paint
Hazard Reducation Act of 1992—Title X
1992). Furthermore, documented evidence
shows that soil lead levels are highest in soil
at the house drip line and greatly decrease
farther away from the house, regardless of
whether or not the house is in a rural area or
city (Jacobs 1995).
Laidlaw et al. (2005) ignored confounding
due to the coexistence of old, poorly main-
tained lead-painted housing and traffic conges-
tion in urban areas. They failed to develop any
rationale to exclude lead paint as a prominent
source of lead exposure and should have
included a measure of it in their models.
Furthermore, they did not support their
assumption that PM10 data can be used as a
surrogate for airborne lead particulate. Laidlaw
et al. should have used the more direct meas-
ures of airborne lead particulate levels, which
are available from the U.S. Environmental
Protection Agency’s (EPA) National Ambient
Air Quality program (U.S. EPA 2004), rather
than the convoluted indirect measures of par-
ticulate matter < 10 µm in diameter (PM10),
soil moisture, and other variables. 
Studies of the effectiveness of soil removal
in urban residential areas without addressing
deteriorated lead paint have demonstrated that
the “soil-only” approach being recommended
by Laidlaw et al. (2005) is of limited value
(U.S. EPA 1996). Even in Superfund sites
where old mining and smelter wastes have
resulted in very high soil lead levels, efforts
that do not also address deteriorated lead paint
often are disappointing. Furthermore, in the
largest and most recent study of lead-based
paint hazard control (which addressed lead
paint hazards in > 3,000 homes in a dozen
jurisdictions), house dust lead levels remained
below preintervention levels for at least
3 years following the intervention (National
Center for Healthy Housing and University
of Cincinnati 2004). In a smaller follow-up
study, dust lead levels remained between 11%
and 75% lower than baseline levels for 6 years
following lead-based paint hazard interven-
tion (Wilson J, Pivetz T, Ashley P, Jacobs D,
Strauss W, Menkedick J, et al., unpublished
data). If the contention of Laidlaw et al.
(2005) is correct (i.e., that urban soil lead is
being resuspended and deposited inside
homes), dust lead levels should have increased
after intervention in these studies. In fact,
they did not. This directly contradicts the
authors’ conclusions.
Finally, Laidlaw et al. (2005) erroneously
cited a pooled analysis (Lanphear et al.
1998), which they believe supports their view
that soil and dust lead are the most signifi-
cant predictors of children’s BPb. In fact, the
model used in that study also included paint
lead and paint condition as variables. If the
dust and soil lead terms are forced out of the
model, paint lead becomes the most signifi-
cant predictor, which is consistent with the
now well-known pathway of paint to settled
house dust and bare soil, to children’s hands,
to ingestion through hand-to-mouth contact.
The pooled analysis (co-authored by D.E.J.)
cannot be used to justify Laidlaw et al.’s
“soil-only” approach.
The latest figures from the National
Health and Nutrition Examination Survey
indicate that the enormous disparity in the
prevalence of BPb levels > 10 µg/dL once
seen between African-American and white
children has diminished greatly [Centers for
Disease Control and Prevention (CDC)
2005]. Overall, the number of children in
the United States with excessive BPb levels
has declined from 890,000 in 1991–1994 to
310,000 in 1999–2002. Much of this is the
result of federal, state, and local efforts to
create a reservoir of lead-safe housing in com-
munities at greatest risk. This success is tem-
pered by recent evidence that a safe BPb level
for children has not been demonstrated. The
lack of a safe threshold reinforces the realiza-
tion that to prevent the adverse health effects
caused by lead exposure, we must exercise the
wisdom to recognize and address the many
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The reality is too complicated and the cost of
failure too devastating to reduce this to a
one-source solution.
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Blood Lead in Children:
Laidlaw et al. Respond
Our article (Laidlaw et al. 2005) is about sea-
sonality of blood lead (BPb) and developing
a predictive model using climatic variables.
It is a new and unique finding about lead,
marked particularly by the fact that it identi-
fies diffuse soil lead as a significant compo-
nent of lead sources in urban children. In
the article, we argued that meteorologic fac-
tors can be robustly applied as a predictor for
seasonal variations in children’s BPb, which
can be used as a potential tool for health care
clinicians in the fight to eliminate lead poi-
soning in youth. We did not intend to
review the literature on lead sources; a vast
literature already exists of such studies.
Suggesting that we propose the “soil-only
hypothesis” completely misconstrues our
work. 
Brown and Jacobs fail to appreciate our
argument that lead accumulation in soil is
from a combination of lead-based paint,
leaded-gasoline, and many other sources, but
is clearly not from lead-based paint alone.
They fail to understand the fact that soil
normally contains very small amounts of
lead, and research from many cities has
shown that there has been an excessive accu-
mulation of lead in inner-cities (Filippelli
et al. 2005; Mielke 2005). We acknowledge
that multiple exposure routes for lead exist
for children and likely influence the
observed seasonality trends in BPb levels
(Laidlaw et al. 2005). We seek to assist with
scientific understanding of how and why
inner-city children are commonly excessively
exposed to lead, and we seek a solution to
that problem. 
We are concerned that people working at
agencies that should champion the reduction
of lead exposure do not appreciate the fact
that multiple sources of lead have accumu-
lated in urban environments and that all
major sources and reservoirs need full atten-
tion if we expect to meet the goals of
Healthy People 2010 (2005). Our work sug-
gests that, to fully address the childhood lead
exposure problem in the United States, a
paradigm shift is required that includes all
major reservoirs of active lead dust. 
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Validity of Anogenital
Distance as a Marker of
in Utero Phthalate Exposure
In their article in the August issue of EHP,
Swan et al. (2005) purport to show that
anogenital distance (AGD) in male infants is
correlated with maternal phthalate exposure
during pregnancy. The AGD has been shown
to decrease in male newborn rats following
maternal exposure to antiandrogens (Gray
et al. 2001). However, little is known regard-
ing AGD in humans, or about effects on
AGD, if any, following in utero hormonal
exposure. Furthermore, significant limitations
in the study undermine the validity of the
correlation reported by these authors. Some
major considerations include the following.
All male infants evaluated in the study
appeared normal (Swan et al. 2005).
Therefore, there is no evidence for potential
adverse effect in the test population.
Because little is known about AGD in
human infants and its variation, no conclu-
sion can be drawn whether the reported
values are normal or abnormal. The range
of AGD values seen among study subjects
likely represents typical biologic variation
that would be expected to occur among
normal study subjects.
The only available historical data on
AGD in male human infants (Salazar-
Martinez et al. 2004) used a different para-
meter for male infants (distance from anus to
the base of the scrotum), which did not show
a similar correlation with maternal phthalate
exposure.
Swan et al. (2005) failed to take into
account the phenotypes of the parents as a
variable that would influence the AGD of
the study subjects, much as other human
anatomical parameters (i.e., height) would
have a genetic component. 
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height, and weight. To compensate for this
variability, Swan et al. (2005) defined a new
parameter, which they termed the “anogeni-
tal index” (AGI), by dividing AGD by body
weight. In the absence of validation, the sig-
nificance of the AGI is not known, and vari-
ation cannot be assumed to be related to
hormonal exposure. Swan et al. suggested
that the AGI is proportional to the normal
genital development of male infants, but
they provided no supporting evidence. Also,
much scatter can be seen in the plot of
“AGI by boy’s age” (Figure 1; Swan et al.
2005). Salazar-Martinez et al. (2004) found
that, in male infants,AGD correlated best
with length, not weight.
Per definition, the AGD represents a
one-dimensional parameter of the human
anatomy. In analogy to similar anatomic
parameters (e.g., length of limbs, hands, or
feet), the AGD is likely to be proportional
to body length and not to body weight.
Therefore, Swan et al.’s use of the (body
weight-related) AGI in the study has little
biologic plausibility and appears to be arbi-
trary.
Swan et al. (2005) did not normalize
maternal phthalate urinary concentrations
for urine volume. This leaves open the pos-
sibility that higher urinary phthalate con-
centrations in individuals may have been
due to lower urinary volume rather that
higher phthalate exposure, and casts doubt
on the maternal exposure classification cate-
gories. Phthalate levels were based on only a
single sample per individual, and fetal devel-
opment at the time of urine sampling was
not reported.
Numerous maternal factors (alcohol
consumption, medication, profession, body
mass) may affect fetal development.
Although it is unknown what factors, if any,
would influence AGD in human infants, in
the absence of these data, confounding fac-
tors cannot be excluded.
The levels of phthalates Swan et al.
(2005) reported in maternal urine samples
are extremely low, and the corresponding
exposures are many orders of magnitude
lower than the exposures at which selected
phthalates have been found to have adverse
reproductive effects in rodents. For exam-
ple, assuming excretion of 2 L of urine/day,
the reported concentration of butyl benzyl
phthalate corresponds to an exposure of
approximately 60 µg/day, or 1 µg/kg/day
for a woman weighing 60 kg. Butyl benzyl
phthalate has been shown to have only
slight, hormone-like effects in rats at doses
of ≥ 100 mg/kg/day (Nagao et al. 2000), or
~ 100,000-fold higher than the levels seen
by Swan et al. (2005). In the case of the
metabolite monoethyl phthalate, the expo-
sure level for the corresponding parent com-
pound diethyl phthalate was on the order of
1,000,000-fold lower than a level found to
have no adverse reproductive effects in rats
(4,000 mg/kg/day, the highest dose tested)
(Scientific Committee on Cosmetic
Products and Non-food Products 2002). It
is biologically and toxicologically inconceiv-
able that such low levels of human exposure
would produce the significant structural dif-
ferences claimed by Swan et al. (2005). 
In summary, the relevance of AGD as
an end point of interest in humans is
entirely speculative, and the correlation
reported by Swan et al. (2005) is lacking in
biologic plausibility and remains unproven.
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Anogenital Distance and
Phthalate Exposure: Swan
et al. Respond
In their letter, McEwen and Renner raise
several points that we would like to discuss. 
First, because all infants in our study
(Swan et al. 2005) appeared normal,
McEwen and Renner infer that there is no
evidence of an adverse effect. However, the
absence of evidence of an effect in infancy
does not preclude serious adverse effects in
later life. For example, the genital cancers
that were identified in young women, on
average 19 years after their prenatal expo-
sure to the drug diethylstilbestrol, were seen
in females who had appeared to be com-
pletely normal until that time (Herbst et al.
1971). In this case, unlike that example, we
do have some evidence of anatomical
changes in young boys. Although anogenital
distance (AGD) has rarely been used as a
measure of androgen action in humans, our
data suggest that shortened AGD reflects
reduced androgen action in utero; AGD was
correlated with the degree of testicular
descent and penile volume, and children
with smaller AGD tended to have smaller
scrotums; these are all signs of reduced
androgen action. 
McEwen and Renner state that the
range of AGD reported in our study (Swan
et al. 2005) is likely to be representative of
normal study subjects. In fact, this informa-
tion is not yet available because this is the
first population-based study that utilized
this measurement. AGD has, however, been
used in the diagnosis of medical conditions
such as congenital adrenal hyperplasia, in
which AGD in females is increased by
excess androgen exposure (Callegari et al.
1987). AGD is also known to be sexually
dimorphic in humans as well as rodents
(Salazar-Martinez et al. 2004).
McEwen and Renner point out that one
previous study [n = 42; (Salazar-Martinez
et al. 2004)] used an alternative measure of
AGD in human infants. However, as we
indicated in our article (Swan et al. 2005),
this alternative definition is less precise than
the one we used and does not correspond to
the measure of anogenital distance most fre-
quently used in toxicologic studies of
rodents. Our use of this measure of AGD
emphasizes the correspondence between tra-
ditional toxicology studies and our study. 
In our study (Swan et al. 2005) we did
not have data that would allow us to con-
sider parental phenotype (e.g. parental
height or father’s AGD), as McEwen and
Renner suggest should be done. If AGD was
affected by parental stature (through infant
body size), this association should be con-
trolled for by adjusting for body size.
Moreover, in order for a phenotypic variable
to explain the observed association, it too
would have to be related to maternal phtha-
late levels. This, too, would be an interest-
ing finding. 
McEwen and Renner question the use
of normalizing AGD by dividing by weight
(AGI) at examination. We examined several
alternative measures of body size and, as dis-
cussed in our article (Swan et al. 2005), AGI
provided the best fit to the data (independent
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(1995) found the same to be true in rodents.
The fact that there was some variation of
AGI with age is to be expected; not all
1-year-olds have the same length, either. 
McEwen and Renner point out potential
sources of “exposure misclassification”
which, we agree, may have been present (and
we stated so) (Swan et al. 2005). However,
unless these sources of measurement error
were related to AGD, their presence would
lead to underestimates of the strength of the
associations we presented. 
We examined a number of potential
confounders, such as maternal smoking and
alcohol consumption; the prevalence of both
was quite low (Swan et al. 2005). None
affected results appreciably. Of course, the
phantom “unmeasured confounder” always
lurks in the wings of any observational
study, can never be ruled out, and is a
favorite of critics of epidemiologic studies.
Any constructive suggestions for alternatives
to observational studies would be appreci-
ated; the only alternative we know of, ran-
domizing pregnant women to receive
phthalates (or not), hardly seems ethical.
Rodent studies test only one phthalate at
a time. As we demonstrated (Swan et al.
2005), women were exposed to measurable
levels of multiple phthalates, many known to
be reproductively toxic. Until we have data
on the toxicology of this complex mixture,
we do not have the information to draw
conclusions about the relative toxicity of
these compounds in rodents versus humans.
Furthermore, although doses in rodent stud-
ies of specific phthalates are high, effects
have been demonstrated at lower doses used
in recent studies (Lehmann et al.).
Unfortunately no toxicologic study has yet
examined effects of phthalates at environ-
mental levels. Because we did find a signifi-
cant association with phthalates at such
levels, we can only conclude that environ-
mental levels, however low, are associated
with somatic alterations in humans. 
Our study (Swan et al. 2005) is rela-
tively small and must be replicated; subse-
quent studies will undoubtedly eliminate
many of the sources of potential exposure
and outcome misclassification. Nonetheless,
in this first study of its kind, we set out to
test the hypothesis, suggested by a large tox-
icologic literature (Gray et al. 2000), that
prenatal phthalate exposure is associated
with several measures in humans that reflect
the antiandrogenic action of these chemi-
cals. Using similar outcome measures to
those utilized in these toxicologic studies,
that is what we found. 
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In the October articles “Children’s Centers
Study Kids and Chemicals” [Environ
Health Perspect 113:A664–A668 (2005)]
and “Are EDCs Blurring Issues of
Gender?” [Environ Health Perspect
113:A670–A677 (2005)], photographs
and their captions erroneously imply that
plastic drink bottles contain ortho-phtha-
lates. Plastic drink bottles sold in the
United States are made from polyethylene
terephthalate and do not contain ortho-
phthalates. Also, at the end of the EDCs
article, references are made to plastic wrap
and Saran Wrap. For clarification, neither
plastic wrap nor Saran Wrap contains
ortho-phthalates. EHP regrets these errors.
EHP regrets the incorrect and uninten-
tional inference in “Paving Paradise: The
Peril of Impervious Surfaces” [Environ
Health Perspect 113:A456–A462 (2005)]
that coal tar pitch is used in the actual
hot-mix asphalt used to pave roads. Coal
tar pitch is instead used in many sealcoat
formulations used atop asphalt pavement.
Findings published in the 1 August 2005
issue of Environmental Science &
Technology suggest, in fact, that coal tar-
based parking lot sealant may be a major
contributor to stream loads of polycyclic
aromatic hydrocarbons, including many
known carcinogens.
In Figure 1 of the article by Chen et al.
[Environ Health Perspect 113:1723–1729
(2005)], the legend should have read
(A)P M 10; (B) PM2.5, instead of (A)P M 2.5;
(B) PM10.
In Figure 1 of the article by Tsan et al.
[Environ Health Perspect 113:1784–1786
(2005)], the double bond between HN
and boron was incorrect. The corrected
figure appears below.
CH3
HN :
CH3
H
H
BH